Cantrell Drug Company in Little Rock, Ark., will become the first human drug compounding outsourcing facility in the United States to use Belgium-based Aseptic Technologies' closed vial system for sterile filling of injectable drugs.
Aseptic Technologies' Crystal Closed Vial Technology reduces the risk of contamination during the compounding process, using lasers to reseal vials once they have been filled with medication.
"This technology represents a revolutionary advance for Cantrell Drug Company, as well as for the sterile product industry in general," said Dell McCarley, CEO of Cantrell Drug Company.
More articles on pharmaceuticals:
FDA warns not to use sterile products from Downing Labs due to lack of quality assurance
340B Program: Time to recertify
Pharma recalls steady, but increasing in complexity